Chronic myelomonocytic leukemia with antecedent refractory anemia with excess blasts: Further evidence for the arbitrary nature of current classification systems

Leukemia and Lymphoma

Volumn 49, Issue 7, 2008, Pages 1292-1296

  Breccia, M ^a   Cannella, L ^a   Frustaci, A ^a   Stefanizzi, C ^a   D'Elia, G M ^a   Alimena, G ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Chronic myelomocytic leukemia; Refractory anemia with excess blasts; Survival; WHO

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; DYSPLASIA; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MALE; MONOCYTOSIS; PRIORITY JOURNAL; PROGNOSIS; REFRACTORY ANEMIA WITH EXCESS BLASTS; RISK ASSESSMENT; STEM CELL; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTE COUNT;

AGED; ANEMIA, REFRACTORY, WITH EXCESS OF BLASTS; BONE MARROW CELLS; DISEASE PROGRESSION; FEMALE; HUMANS; LEUKEMIA, MYELOMONOCYTIC, CHRONIC; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; WORLD HEALTH ORGANIZATION;

EID: 47649131943     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190802123499     Document Type: Article

References (19)

1. Bennett, J. M., Catovsky, D., Daniel, M. T., Flandrin, G., Galton, D. A. Gralnick, H. R. et al. (1982) Proposals for the classification of the myelodysplastic syndromes. Br J Haematol, 51, pp. 189-199.
2. Tefferi, A. and Vardiman, J. W. (2008) Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia, 22, pp. 14-22.
3. Onida, F., Kantarjian, H. M., Smith, T. L., Ball, G., Keating, M. J. Estey, E. H. et al. (2002) Prognostic factors and scoring systems in chronic myelomonocytic leukemia: A retrospective analysis of 213 patients. Blood, 99, pp. 840-849.
4. Gonzalez-Medina, I., Bueno, J., Torrequebrada, A., Lopez, A., Vallespi, T. and Massague, I. (2002) Two groups of chronic myelomonocytic leucemia: Myelodysplastic and myeloproliferative. Prognostic implications in a series of a single center. Leuk Res, 26, pp. 821-824.
5. Germing, U., Gattermann, N., Minning, H., Heyll, A. and Aul, C. (1998) Problems in the classification of CMML-dysplastic versus proliferative type. Leuk Res, 22, pp. 871-878.
6. Noesslinger, T., Reisner, R., Gruner, H., Tuchler, H., Nowotny, H. and Pittermann, E. (2001) Dysplastic versus proliferative CMML. A retrospective analysis of 91 patients from a single institution. Leuk Res, 25, pp. 741-747.
7. Voglova, J., Chrobak, L., Neuwirtova, R., Malaskova, V. and Straka, L. (2001) Myelodysplastic and myeloproliferative type of chronic myelomonocytic leukaemia: Distinct subgroups or two stages of the same disease. Leuk Res, 25, pp. 493-499.
8. Breccia, M., Latagliata, R., Mengarelli, A., Biondo, F., Mandelli, F. and Alimena, G. (2004) Prognostic factors in myelodysplastic and myeloproliferative types of chronic myelomonocytic leukemia: A retrospective analysis of 83 patients from a single institution. Haematologica, 89, pp. 866-868.
9. (1995) International Standing Committee on Human Cytogenetic Nomenclature. An International System for Human Cytogenetic Nomenclature, S. Karger AG, Basel, Switzerland
10. Mufti, G. J., Stevens, J. R., Oscier, D. G., Hamblin, T. J. and Machin, D. (1985) Myelodysplastic syndromes: A scoring system with prognostic significance. Br J Haematol, 59, pp. 425-433.
11. Sanz, G. F., Sanz, M. A., Vallespi, T., Canizo, M. C., Torrabadella, M. Garcia, S. et al. (1989) Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients. Blood, 74, pp. 395-408.
12. Greenberg, P., Cox, C., LeBeau, M. M., Fenaux, P., Morel, P. Sanz, G. et al. (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood, 89, pp. 2079-2088.
13. Rigolin, G. M., Cuneo, A., Roberti, M. G., Bardi, A. and Castoldi, G. (1997) Myelodysplastic syndromes with monocytic component: Hematologic and cytogenetic characterization. Haematologica, 82, pp. 25-30.
14. Castoldi, G. and Rigolin, G. M. (2001) The monocytic component in myelodysplastic syndromes. Cancer Treat Res, 108, pp. 81-92.
15. Beran, M., Shen, Y., Onida, F., Wen, S., Kantarjian, H. and Estey, E. (2006) Prognostic significance of monocytosis in patients with myeloproliferative disorders. Leuk Lymphoma, 47, pp. 417-423.
16. Ohyashiki, K., Yokoyama, K., Kimura, Y., Ohyashiki, J. H., Ito, T. Kuratsuji, T. et al. (1993) Myelodysplastic syndromes evolving into myeloproliferative disorders: One disease or two. Leukemia, 7, pp. 388-340.
17. Verhoef, G EG, De Wolf-Peeters, C., Ferrant, A., Deprez, S., Meeus, P. Stul, M. et al. (1991) Myelodysplastic syndromes with bone marrow fibrosis: A myelodysplastic disorder with proliferative features. Ann Hematol, 63, pp. 235-241.
18. Verhoef, G EG, Demuynck, H., Zachee, P. and Boogaerts, A. (1994) Myelodysplastic syndromes evolving into myeloproliferative disorders: one disease or two. Leukemia, 8, pp. 714-715.
19. Rosati, S., Mick, R., Xu, F., Stonys, E., Le Beau, M M, Larson, R. and Vardiman, J. W. (1996) Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome. Leukemia, 10, pp. 20-26.